Cardiorespiratory depression and hyperglycemia after unintentional ingestion of brimonidine in a neonate

European Journal of Ophthalmology

Volumn 19, Issue 4, 2009, Pages 694-695

  Vanhaesebrouck, Sophie ^a   Cossey, Veerle ^a   Cosaert, Katrien ^a   Allegaert, Karel ^a   Naulaers, Gunnar ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Bradycardia; Brimonidine; Hyperglycemia; Neonates; Somnolence

Indexed keywords

1 ALPHALEO; ANTIBIOTIC AGENT; BICARBONATE; BRIMONIDINE; CEFADROXIL; OXYBUTYNIN; UNCLASSIFIED DRUG;

APNEA; ARTICLE; BRADYCARDIA; CARDIOPULMONARY INSUFFICIENCY; CASE REPORT; CHILD HEALTH CARE; DRUG INTOXICATION; DRUG SAFETY; HUMAN; HYPERGLYCEMIA; INFECTION; KIDNEY FAILURE; LABORATORY TEST; MALE; MEDICATION ERROR; NEWBORN; NEWBORN INTENSIVE CARE; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SEDATION; SOMNOLENCE;

ADRENERGIC ALPHA-AGONISTS; ANTIHYPERTENSIVE AGENTS; BRADYCARDIA; HUMANS; HYPERGLYCEMIA; INFANT, NEWBORN; MALE; MEDICATION ERRORS; QUINOXALINES; RESPIRATORY INSUFFICIENCY;

EID: 70549087868     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210901900429     Document Type: Article

References (6)

1. Berlin RJ, Lee U, Samples J, et al. Ophthalmic drops causing coma in an infant. J Pediatr 2001; 138: 441-3.
2. Bowman RJ, Cope J, Nischal KK. Ocular and systemic side effects of brimonidine 0.2% eye drops (Alphagan®) in children. Eye 2004; 18: 24-6.
3. Daubert GP. Is brimonidine ophthalmic a safe therapy for infants? J Clin Pharm Ther 2006; 31: 289-92.
4. Mungan NK, Wilson TW, Nischal KK, Koren G, Levin AV. Hypotension and bradycardia in infants after the use of topical brimonidine and beta-blockers. J AAPOS 2003; 7: 69-70.
5. Suwanwipat S, Buranakarl C, Chaiyabutr N. Effects of brimonidine ingestion on cardiovascular responses and renal function in conscious dogs. Vet Res Commun 2007; 31: 323-4.
6. Walters T. Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies. Surv Ophthalmol 1996; 41: S19-S26.